Target
CD105
2 abstracts
Abstract
A randomized phase II study of apalutamide with or without carotuximab (ant-CD105) in metastatic, castration-resistant prostate cancer.Org: Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Huntsman Cancer Institute at the University of Utah, Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center,
Abstract
Unveiling the prognostic significance of BCL6+/CD10+ mantle cell lymphoma: A systematic analysis.Org: Division of Medical Oncology and Hematology, Loma Linda University School of Medicine, Loma Linda, CA, Department of Internal Medicine school of Medicine, University of California San Francisco, Fresno, CA, Loma Linda University Department of Internal Medicine, Loma Linda, CA, Division of Medical Oncology and Hematology, Loma Linda University of Medicine, Loma Linda, CA, Internal medicine, Loma Linda University health, Loma Linda, CA,